McDonald Partners’s Pediatrix Medical MD Stock Holding History

McDonald Partners’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-9	Closed	-$245	–	542
2021 Q4	$245	Buy	+9	New	+$241	﹤0.01%	538

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

McDonald Partners's MD Position: Q1 2022 in Review

McDonald Partners sold out of Pediatrix Medical (MD) in Q1 2022, closing a stake of 9 shares — an estimated $245 sold.

McDonald Partners first reported a position in MD in Q4 2021 and held it in 1 quarter. The position peaked at $245 in Q4 2021. 224 funds tracked by Wall St. Rank hold MD as of Q1 2022.

McDonald Partners reported no remaining Pediatrix Medical position as of Q1 2022 after selling out during the quarter.
McDonald Partners sold 9 Pediatrix Medical shares in Q1 2022, an estimated $245.
McDonald Partners first reported a position in Pediatrix Medical in Q4 2021 and held it in 1 quarter.
McDonald Partners's Pediatrix Medical position peaked at $245 in Q4 2021.
224 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2022.

Based on McDonald Partners's 13F filing for Q1 2022, filed 29 Apr 2022.